Delivery Order 140D0423D0020-9594CS26F0012
- Not listed
- Quest Diagnostics Clinical Laboratories, Inc. has been awarded a delivery order valued at $560,946.55 for drug and alcohol laboratory testing services under a Department of the Interior contract. The award, issued on April 1, 2025, with an ultimate completion date of March 31, 2026, represents a firm fixed-price engagement with no small business set-aside designation. Performance will be conducted at Quest Diagnostics' facility in Secaucus, New Jersey. This delivery order is structured under...
- The Court Services and Offender Supervision Agency (CSOSA) awarded a delivery order valued at $1,772.25 to Quest Diagnostics Clinical Laboratories, Inc. for drug laboratory testing services. This firm fixed-price delivery order was issued on April 1, 2023, with an ultimate completion date of February 29, 2024, and was performed in Washington, DC. The award carries no small business set-aside designation, reflecting the competitive nature of Quest Diagnostics' federal market position as a leading...
- This is a delivery order awarded by the Court Services and Offender Supervision Agency (CSOSA), a civilian federal agency, to Quest Diagnostics Clinical Laboratories, Inc., a for-profit organization, for laboratory testing analysis services. The award has a ceiling value of $7,828.00 and a final completion date of February 28, 2026. The contract is a firm fixed-price delivery order without a small business set-aside designation. Quest Diagnostics has worked extensively with federal agencies,...
- Quest Diagnostics Clinical Laboratories, Inc., doing business as Quest Diagnostics, has been awarded a $386,156.45 time-and-materials delivery order against the Department of the Interior's indefinite delivery, indefinite quantity (IDIQ) contract for drug and alcohol testing services. As the prime contractor, Quest Diagnostics will provide clinical laboratory testing from May 1, 2022 through April 30, 2023 in support of the Interior Department's workplace drug testing program. Performance will...
- This federal contract award, valued at $521,977.45, is for Drug and Alcohol Testing (DAT) Specimen Laboratory Analysis Services, provided by Quest Diagnostics Clinical Laboratories, Inc. (doing business as Quest Diagnostics) to the U.S. Department of the Interior's Interior Business Center. The contract is a Delivery Order under a larger Indefinite Delivery Indefinite Quantity (IDIQ) contract with a ceiling value of $3.9 million, which facilitates ongoing laboratory services for federal...
- This federal contract award, CSOSA17A0005|9594CS19F0029, was issued by the Community Supervision and Offender Services Administration (CSOSA) to Quest Diagnostics Clinical Laboratories, Inc., doing business as Quest Diagnostics. The contract, a Blanket Purchase Agreement (BPA) call order, is for clinical laboratory testing services. The contract has a firm fixed price of $15,738.46 and a completion date of April 9, 2020. The contract was awarded on April 10, 2019 and does not have a set-aside...
- Quest Diagnostics Clinical Laboratories, Inc., a large business contractor specializing in clinical laboratory testing services, received a $16,779 firm fixed-price delivery order from the U.S. Marshals Service Human Resources Division for fiscal year 2026 drug and alcohol laboratory testing. The award was issued on March 1, 2026, with an ultimate completion date of February 28, 2027, and performance will take place at the contractor's facility in Secaucus, New Jersey. No small business...
- This is a delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated. The $9,685,535.71 firm fixed-price contract does not have a set-aside designation. It was awarded on April 7, 2016 with a completion date of May 6, 2020, and provides clinical laboratory testing services to support various federal healthcare, law enforcement, and workplace...
- This contract was awarded by the Department of the Interior to Quest Diagnostics Clinical Laboratories, Inc., doing business as Quest Diagnostics, to provide drug and alcohol testing services. The $58,577.75 firm fixed-price delivery order is not associated with a small business set-aside. Quest Diagnostics is a subsidiary of the parent company Quest Diagnostics Incorporated, a leading provider of diagnostic laboratory services to federal agencies. The Department of the Interior has previously...
- Quest Diagnostics Incorporated received a $8,983.26 firm fixed-price Blanket Purchase Agreement (BPA) call from the Court Services and Offender Supervision Agency (CSOSA) for laboratory testing services during fiscal year 2024, with the award issued on October 1, 2023, and ultimate completion by September 28, 2024. This contract represents a de-obligation of unused FY24 funds and was awarded without a set-aside designation under the Medical Laboratory Testing and Analysis Services Federal Supply...
- 140D0423D0020Indefinite Delivery Contract
- 140D0423D0020-9594CS26F0012Delivery Order
The U.S. Department of the Interior's Court Services and Offender Supervision Agency (CSOSA) awarded a delivery order valued at $5,000 to Quest Diagnostics Clinical Laboratories, Inc. on March 30, 2026, for laboratory testing analysis services. This task order was issued under the Department of the Interior's single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by Quest Diagnostics, which was established on February 1, 2023, with a total ceiling value of $3.94 million and an ultimate completion date of January 31, 2028. The award carries no small business set-aside designation and operates on a firm fixed-price basis, with performance to be completed by February 28, 2027, at the contractor's facility in Washington, DC. Quest Diagnostics, a large business subsidiary of Quest Diagnostics Incorporated headquartered in Secaucus, New Jersey, specializes in comprehensive clinical laboratory testing services including drug and alcohol testing through analysis of urine, oral, and breath specimens for controlled substances such as marijuana, cocaine, opioids, amphetamines, and fentanyl. The parent IDIQ contract has generated substantial task order activity exceeding $1.6 million in delivery orders across multiple federal agencies supporting law enforcement operations and offender monitoring programs. This delivery order represents continued utilization of that vehicle to support CSOSA's offender supervision and monitoring mission through rapid specimen analysis services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 3/29/26 |